EUVIMEDEUVIMED entdecken
Open Access

Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis.

Figen Öztürk Ergür, Ayperi Öztürk, Barış Akgül, Aydın Yılmaz, Ömür Güngör

Sarcoidosis vasculitis and diffuse lung diseases · 22.06.2026 · 43 (2) · 18084-18084

DOI: 10.36141/svdld.2026.18084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 22.06.2026. Verfasst von Figen Öztürk Ergür und 4 weiteren Autor:innen. Beteiligte Einrichtung: Atatürk Sanatoryum Training and Research Hospital, Department of Pulmonary Medicine, Ankara, Turkey. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Hypersensitivity pneumonitis (HP) is a complex interstitial lung disease with heterogeneous presentations. In some patients, radiological coexistence of emphysema and fibrosis creates a distinct functional phenotype that complicates disease progression and management. To evaluate the functional impact of combined emphysema and fibrosis in HP patients and to identify clinical predictors associated with this dual pathology. METHODS: We retrospectively analyzed 215 patients diagnosed with HP between 2010 and 2023. Demographic data, exposure history, radiological findings (HRCT), and pulmonary function parameters (FVC, DLCO, FEV₁) were collected. Patients were classified into three groups: fibrotic HP, non-fibrotic HP, and combined emphysema with fibrosis (CE-HP). Statistical analyses were performed using SPSS v22.0. RESULTS: Of the 215 patients, 68 (31.6%) had fibrotic HP and 42 (19.5%) presented with CE-HP. Patients with CE-HP were significantly older (mean 66.2 ± 9.1 years) and more often male and smokers (p 65 years, male gender, and smoking history were independent predictors of CE-HP development. CONCLUSIONS: The coexistence of emphysema and fibrosis in HP represents a distinct clinical phenotype with significant functional impairment. Recognition of this dual pathology is crucial for accurate prognostication and individualized management strategies.

Schlagwörter

hypersensitivity pneumonitisemphysemapulmonary fibrosisinterstitial lung diseaselung functiondiffusing capacity for carbon monoxideforced vital capacitysmokingrisk factorsclinical phenotype

Autor:innen und Institutionen

  • Atatürk Sanatoryum Training and Research Hospital, Department of Pulmonary Medicine, Ankara, Turkey.
  • Adana City Training and Research Hospital, Department of Pulmonary Medicine, Adana, Türkiye.

Zitieren

APA

Öztürk Ergür, F., Öztürk, A., Akgül, B., Yılmaz, A., & Güngör, Ö. (2026). Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis. Sarcoidosis vasculitis and diffuse lung diseases, 43(2), 18084-18084. https://doi.org/10.36141/svdld.2026.18084

Vancouver

Öztürk Ergür F, Öztürk A, Akgül B, Yılmaz A, Güngör Ö. Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(2):18084-18084. doi:10.36141/svdld.2026.18084

BibTeX
@article{ztrkErgr2026,
  author = {Öztürk Ergür, Figen and Öztürk, Ayperi and Akgül, Barış and Yılmaz, Aydın and Güngör, Ömür},
  title = {Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2026},
  volume = {43},
  number = {2},
  pages = {18084--18084},
  doi = {10.36141/svdld.2026.18084}
}
Kostenlos starten →